Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma both referred to 340B—obliquely in Azar’s case, directly in Verma’s—in recent farewell remarks.
In an interview with Modern Healthcare published Jan. 14, Verma cited CMS’s nearly 30 percent cut in Medicare Part B drug reimbursement for 340B hospitals as one of the most significant changes to Medicare during her tenure. She also described it as blow against monopoly power. The Trump administration never couched the policy in those terms before.
Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma both referred to 340B—obliquely in Azar’s case, directly in Verma’s—in recent farewell remarks.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
